newsfilter
← Latest News
GlobeNewswire·

Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104

TORONTO, April 05, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ:FTRP, TSX:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, today announced that the U.S. Patent and Trademark Office ("USPTO") has